Stephen M. Prescott, MD
Stephen Prescott, MD, became the ninth president of the Oklahoma Medical Research Foundation (OMRF) in the spring of 2006. A leader in studies of the basic mechanisms of human disease, Prescott came to OMRF from the University of Utah, where he founded the innovative Eccles Program in Human and Molecular Biology & Genetics and also served as the executive director of the Huntsman Cancer Institute, an NCI-designated cancer center.
At OMRF, Prescott has initiated the largest campus expansion in the foundation’s 63-year-history. In early 2009, OMRF began construction of a research tower that, when completed, will nearly double the size of OMRF’s laboratory facilities and will add 300 scientists, technicians, and support personnel to OMRF’s current 525-person staff. The new research tower will be a one-of-a-kind "green" facility, expected to earn gold-level LEED certification. When completed, it is believed the OMRF tower will be the first medical research facility anywhere powered, in part, by wind and solar energy.
A native of Texas and an undergraduate at Texas A&M University, Prescott received his MD from the Baylor College of Medicine prior to completing his training in internal medicine at the University of Utah. He then undertook advanced research training at Washington University School of Medicine (St. Louis). In 1982, Prescott joined the faculty of the University of Utah, where he became a professor of internal medicine and held the H.A. & Edna Benning Presidential Endowed Chair. He has authored more than 250 scientific articles and has trained over 40 research students and postdoctoral fellows.
Prescott served as a senior editor of the influential Journal of Biological Chemistry and Journal of Clinical Investigation. He also served on advisory committees for the National Institutes of Health, the American Heart Association, the American Cancer Society, and multiple universities. He has been elected to the American Association for the Advancement of Science, the Association of American Physicians, the American Society for Clinical Investigation, the Royal College of Physicians in Ireland, and the Royal Academy of Medicine in Spain. Prescott was a member of the board of the American Red Cross Biomedical Division and the National Human Genome Research Institute’s Advisory Council. He was a member of the Institute of Medicine Committee on Large-Scale Science and Cancer Research and chaired the Utah Governor’s Task Force on Technology Transfer. Among other awards, he has received the Utah Governor’s Medal for Science and Technology, the Houssay-Braun-Menendez Medal from the Argentine Association for the Advancement of Science, and the Sol Sherry Prize from the American Heart Association.
Prescott has consulted for pharmaceutical and biotechnology companies in the United States, Europe, and Japan, and has served on the scientific advisory board or board of directors of four biotechnology companies. He is the founder of LineaGen, a biotechnology company. In 2006, following nomination by President George W. Bush and confirmation by the U.S. Senate, Prescott joined the Board of Trustees for the Udall Foundation.